Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
Discover the latest content that has just been published on Research Tree
• The net result swung from a loss of $442m for Q3 22 to a profit of $1.02bn for Q3 23 • The segments participated in the lower claims and higher interest rates • RoI increased from 1.6% for 9M 23 to 3.5% for 9M 23 • Management confirmed the full year profit target of more than $3bn for FY2023
Companies: Swiss Re AG
AlphaValue
• Net profit rose from weak $157m for H1 22 to $1.45bn for H1 23 • RoI was up to 2.8% for H1 23 compared to 1.2% for H1 22 • P&C achieved successful July renewal • Management confirmed the full year profit target of above $3bn for FY2023
• Net premiums earned rose by 4% to $11.1bn for Q1 23 • RoI improved from 0.7% for Q1 22 to 2.8% for Q1 23 • The net result swung from a loss of $248m for Q1 22 to a profit of $643m for Q1 23 • Treaty premium volumes increased by 5% in the April renewals
• Net profit attributable to shareholders decreased by 67% to $472m for 2022 compared to 2021. EPS was only CHF1.63 for FY2022 compared to CHF4.52 for FY2021 • Management proposes a dividend of CHF6.40 per share for FY2022 after CHF5.90 for FY2021. • Swiss Re renewed $10.2bn in premium volume on 1 January 2023, representing an increase of 13%. • Swiss Re targets net income of more than $3bn for 2023 and RoE of 14% for 2024
• Swiss Re estimates its preliminary claims from Hurricane Ian at approximately $1.3bn in Q3 22 • Expected Group net loss of approximately $0.5bn for Q3 22 • ROE target of 10% for 2022 is unlikely to be reached
• Net profit declined by 85% to $157m for H1 22 but Q2 22 profit was $405m • RoI was down to 1.2% for H1 22 compared to 3.2% for H1 21 due to listed equity losses of $426m • P&C achieved a price increase of 12% in July renewal • Shareholders´ equity declined by 37% in H1 22, mainly due to $7.5bn of unrealised investment losses.
• Net premiums earned rose by 4% to $10.6bn • Impact of the COVID-19 on the underwriting result of the group was $524m for Q1 22 • Net result was a loss of $248m for Q1 22 compared to a profit of $333m for Q1 21 • Treaty premium volumes increased by 15% in the April renewals
• Net result increased from a loss of $878m for 2020 to a profit of $1.44bn for 2021. • Management proposed an unchanged dividend of CHF5.90 per share for FY2021. • Swiss Re renewed $8.9bn in premium volume on 1 January 2022, representing an increase of 6%. • Swiss Re announced a new group RoE target of 10% for 2022 and 14% for 2024
• Net premiums earned rose by 6% for 9M 21. • Net result was a profit of $1.26bn for 9M 21 compared to a loss of $691m for 9M 20. • COVID-19-related claims and reserves declined from $3.0bn for 9M 20 to $1.27bn for 9M 21. • Net income of $212m for Q3 21 was above consensus expectations of a loss of $81m.
• Net result was a profit of $1.05bn for H1 21 compared to a loss of $1.13bn for H1 20. • Impact of the COVID-19 crisis on the underwriting result of the group was $870m for H1 21 compared to $2.5bn for H1 20. • Treaty premium remained largely stable but the price improved by a nominal 4% in the July renewals. • Shareholders´ equity declined by 12% in H1 21, mainly due to $2.5bn unrealised investment losses.
• Net premiums earned rose by 7% to $10.2bn • Impact of the COVID-19 crisis on the underwriting result of the group was $643m for Q1 21. • Net result was a profit of $333m for Q1 21 compared to a loss of $225m for Q1 20 • Treaty premium volumes increased by 20% in the April renewals
Net loss was $878m for 2020 and higher than consensus expectations. Management proposed an unchanged dividend of CHF5.90 per share for FY2020. Swiss Re renewed $7.8bn in premium volume on 1 January 2021, representing a decrease of 11%.
• Net premiums earned rose by 6% for 9M 20. • Net result attributable to shareholders was a loss of $691m for 9M 20 compared to net income of $1.34bn for 9M 19. • COVID-19-related claims and reserves rose from $2.5bn for H1 20 to $3.0bn for 9M 20. • Net income of $444m for Q3 20 was above consensus expectations of $248m.
• COVID-19-related claims and reserves rose from $0.5bn for Q1 20 to $2.5bn for H1 20 • Net loss of c.$1.1bn for H1 20 compared to a net profit of $953m for H1 19 • Closing of ReAssure sale pushed the SST ratio above the target level of 220%, despite the significant claims and reserves set up in H1 20
• Net premiums earned rose by 7% to $9.6bn • $476m claims for cancelled or postponed events and a mark-to-market charge of $251m pre-tax due to the decline in the Phoenix share price. • Net result was a loss of $225m for Q1 20 • Treaty premium volumes increased by 4% in the April renewals
Research Tree provides access to ongoing research coverage, media content and regulatory news on Swiss Re AG. We currently have 1 research reports from 5 professional analysts.
Target Healthcare REIT’s Q324 update shows a fifth successive quarter of positive NAV total return, with indexed rent reviews driving increased earnings and property values. Tenant profitability continues to strengthen, reflected in a high level of rent cover and rent collection. Dividends are well covered by adjusted earnings and we expect further DPS growth.
Companies: Target Healthcare REIT PLC
Edison
Performance of clean energy shares was weak in 2023 other than in storage. 2024 is likely to see storage continue to perform but renewables, bioenergy and hydrogen could also see an improved environment in the year. While elections in the US and the EU could result in weaker support for clean energy, these are to an extent offset by progress at COP28 and the extent to which electorates recognise climate change in the face of almost unavoidable evidence.
Companies: PV1 TLG DRX PHE CYAN NESF AGLX EQT IES CORRE REFL ATOM
Longspur Clean Energy
The focus of Hardman & Co Research is on the nine quoted Infrastructure Investment Companies (IICs) and on the 22 Renewable Energy Infrastructure Funds (REIFs): the stocks analysed are all members of the Association of Investment Companies (AIC). We are updating our publication of January 2023, assessing both the lacklustre share price performances during 2023 and the key issues, including interest rates, inflation and power prices. As a 31-strong group, its combined market capitalisation is no
Companies: AEIT ROOF DGI9 INPP GSF SEIT USFP HICL ORIT BSIF TRIG NESF SEQI HEIT GRP GCP FSFL 3IN AERI PINT RNEW BBGI GSEO DORE TENT GRID CORD HGEN AEET
Hardman & Co
IPU is seeking to capitalise on a potential UK recovery by increasing gearing…
Companies: Invesco Perpetual UK Smaller Companies Investment Trust PLC
Kepler | Trust Intelligence
TRIG’s portfolio continues to evolve, despite equity capital markets being closed…
Companies: Renewables Infrastructure Group Limited GBP Red.Shs
The Hardman & Co Healthcare Index (HHI) has been running since 2009. Its main function is to highlight the attractions of life sciences investments over the long term. For the second year running, apart from global economic influences affecting world markets, performance in 2023 was dented by the capital-intensive nature of the sector. The HHI fell 3.7%, to 483.8, underperforming the main London markets – FTSE 100 (+3.8%) and FTSE All-Share (3.8%) but outperforming the FTSE AIM All-Share Index (
Companies: TXG ETXPF NDVA TSVT BCOW Z29 TXG NCYT GNS SUN AMS OMG APH EKF EAH IMM AGL DEMG AGY TSTL IPO GDR TRX HVO CTEC OXB DEST VLG IXI VAL INDV AGR AVCT BAI 123F IMCR BCOW
Avation, a lessor of 34 commercial aircraft, provided a trading update on Friday for the year to date, reporting a significant expected increase in the value of its ATR 72 purchase rights, along with an improvement in lease revenues and cash collections. Following the announcement of a restructured aircraft purchasing plan with ATR earlier this month, the company has reported that the grant of new aircraft purchase rights and the extension of the existing rights is expected to increase the value
Companies: Avation PLC
WHIreland
With its focus on high-quality omnichannel supermarkets, Supermarket Income REIT (SUPR) is very well positioned to benefit from strong growth trends in the grocery sector, supportive of its income proposition and capital values. The company is confident that the targeted FY24 DPS of 6.06p (+1%) will be fully covered as adjusted earnings benefit from rental growth, cost efficiency and fixed debt costs.
Companies: Supermarket Income REIT Plc
AUM was up by £2.2bn or 6% over H1-24, reaching £39.6bn on 31 Mar 24 (30 Sep 23: £37.4bn). This was a top-third growth rate among a London-listed peer group. While sustainable investing flows around the world have been subdued, we are seeing some early signs of a return to stronger flows. H1-24 revenue of £86.2m was down 2% y-o-y from £88.0m in H1-23 on lower average AUM levels and an unchanged average fee margin of 45bps. However, an AUM recovery during the period saw run-rate revenue increase
Companies: Impax Asset Management Group plc
Equity Development
finnCap announced this morning a proposed new CEO and the appointment of new directors. Sam Smith, finnCap’s CEO, has announced her intention to step down from the position and move into an advisory role within the group. John Farrugia, currently Managing Partner of finnCap Cavendish, will become a director of the group and then CEO after Sam Smith steps down.
Companies: Cavendish Financial PLC
Progressive Equity Research
Tern’s FY23 results highlight improving metrics that should attract additional strategic interest across the portfolio. All companies are gaining significant commercial traction, with configuration work turning to repeat licencing through SaaS models and growing high-profile customer bases. However, valuations across the global technology landscape remain depressed, which has flowed through to Device Authority and Wyld, as detailed overleaf. Therefore, despite the significant improvement in perf
Companies: Tern PLC
Companies: UTL ASC DNLM BWNG MONY DFS BOO
Shore Capital
Canaccord Genuity
Last year the five-strong team at Kepler Trust Intelligence – including analysts and mere mortals – chose a trust each as our personal ‘top pick’ for 2019 and we will be reporting back on the performance of those trusts in early January, once the final numbers are in for this tumultuous year. In the meantime I can reveal that an investment of £5,000 spread equally across our selections, made on 1st January 2019, would at the time of writing be worth a cool £6,349 today and that performance puts
Companies: BRWM IEM JUGI TFG
Much has been written about the effects of the virus on the world and on the stock market. Here is one analyst’s take on some of the likely impacts on the way we should look at companies. This article was originally produced as a blog, “10 Changes Post Virus”, which was published a few weeks ago.
Companies: RE/ SCE ARBB AGY RECI GDR TRX PCA PHNX PHP STX SHED VTA 3HY PIN
Share: